Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05849597
Other study ID # 612-1/1
Secondary ID
Status Recruiting
Phase Phase 3
First received
Last updated
Start date March 1, 2022
Est. completion date December 2024

Study information

Verified date May 2023
Source University of Novi Sad
Contact Mihaela Preveden, MD
Phone +381214805702
Email mihaela.detki@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, randomized, single blinded, controlled clinical trial designed to compare the clinical effects of sedation with dexmedetomidine versus propofol in patients undergoing cardiac surgery.


Description:

The study will include adult patients of both sexes scheduled for elective cardiac surgery with the use of cardiopulmonary bypass (including coronary artery bypass grafting, valve repair/replacement, and combined). The patients included in the study will be randomized in 1:1 ratio using computer generated numbers into two groups. The first group of patients, upon arrival to the intensive care unit will be sedated with continuous dexmedetomidine infusion in doses 0.2-0.7 mcg/kg/h. Dexmedetomidine infusion will be discontinued before weaning from mechanical ventilation and extubation. The second group of patients, upon arrival to the intensive care unit will be sedated with continuous propofol infusion in doses 1-2 mg/kg/h. Propofol infusion will also be discontinued before weaning from mechanical ventilation and extubation. Sedation level will be assessed using Richmond Agitation and Sedation Scale (RASS) every two hours. Postoperative analgesia will be managed according to protocol (opioid analgesics, non-steroid anti-inflammatory drugs, paracetamol), with pain level assessment using visual analog scale (0 - no pain; 10 - unbearable pain). The following data will be registered: age, sex, body mass index (BMI), hemoglobin, heart rate, and LVEF. Among the postoperative parameters, the following will registered: duration of mechanical ventilation (in hours), extubation time, ICU and hospital length of stay (in days), postoperative hemoglobin, blood product transfusion rates, occurrence of atrial fibrillation and assessment of delirium. Assessment of delirium will be performed using the confusion assessment method for intensive care unit (CAM-ICU) every 12 hours during five postoperative days.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 2024
Est. primary completion date April 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patients undergoing open heart surgery with the use of cardiopulmonary bypass (including coronary artery bypass grafting, valve repair/replacement, and combined) - left ventricular ejection fraction (LVEF) >40%. Exclusion Criteria: - preoperative atrial fibrillation - previous history of interventionally treated arrhythmias - second and third degree atrioventricular block - bradycardia with heart rate =50/min - pacemaker - renal or hepatic insufficiency - emergency procedures - history of serious mental illness, delirium, and severe dementia

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Dexmedetomidine
Upon arrival to the intensive care unit after open heart surgery, the patients will be sedated with continuous dexmedetomidine infusion in doses 0.2-0.7 mcg/kg/h.
Propofol
Upon arrival to the intensive care unit after open heart surgery, the patients will be sedated with continuous propofol infusion in doses 1-2 mg/kg/h.

Locations

Country Name City State
Serbia Institute of Cardiovascular Diseases of Vojvodina Sremska Kamenica

Sponsors (1)

Lead Sponsor Collaborator
University of Novi Sad

Country where clinical trial is conducted

Serbia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence of postoperative delirium Assessment of delirium will be performed using the confusion assessment method for intensive care unit (CAM-ICU) at any time in the first five days after surgery 5 days
Secondary MV duration Duration of mechanical ventilation 30 days
Secondary ICU length of stay Total duration of stay in the intensive care unit 30 days
Secondary Hospital length of stay Total duration of stay in hospital 30 days
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Completed NCT04529395 - Impact of Aromatherapy on the Delirium of Patients in Intensive Care Unit N/A
Active, not recruiting NCT05082623 - The Effect of Music on Delirium, Pain, Need of Sedation, Anxiety and Vital Parameters N/A
Recruiting NCT04305600 - Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction in ICU Survivors, 2nd Study
Completed NCT04218461 - PREdiction of DELIRium in Medical ICU Patients
Recruiting NCT05467410 - Optimal Timing of Computerized Cognitive Training for Older Intensive Care Unit Survivors N/A
Completed NCT04080557 - Abdominal Aortic Aneurysm Patients Remain at Risk for Delirium on the Surgical Ward After Intensive Care Unit Dismissal
Recruiting NCT04957238 - Physical Restraints in Intensive Care Unit Patients N/A
Active, not recruiting NCT04182334 - Decreasing Delirium Through Music in Critically Ill Older Adults N/A
Recruiting NCT06355570 - Delirium After Cardiac Surgery in Intensive Care Units N/A
Recruiting NCT04312893 - The Effectiveness of Acupuncture for Delirium in Critically Ill Patients N/A
Recruiting NCT06029244 - Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE) N/A
Completed NCT06279390 - PRE-DELIRIC Prediction Model Plus SMART Care to Reduce the Incidence of Delirium in ICU Patients
Recruiting NCT05936944 - Role of Natural Light in the Prevention of Delirium After Cardiac Surgery: a Prospective Observational Study With Historical Control
Completed NCT05401461 - Mobilisation in the EveNing to TreAt Delirium N/A
Recruiting NCT04812041 - Relationship Between Delirium Severity by CAM-ICU 7 and 4C Mortality Score of the COVID-19 Patients in ICU
Recruiting NCT06172491 - Automating Delirium Severity in the ICU
Active, not recruiting NCT04099472 - Partnering With Family Members to Prevent, Detect and Manage Delirium in Critically Ill Patients. N/A
Not yet recruiting NCT06030453 - Using SMART HOME Strategy to Reduce the Incidence of Delirium in the Intensive Care Unit N/A
Completed NCT05027217 - Sedation, ANalgesia and Delirium MANagement in Intensive Care Unit